I now have comprehensive information from multiple authoritative sources. Here is a full answer:
Potts Shunt
You likely meant the Potts shunt (not "Gotts"). This is a well-established surgical procedure in congenital heart disease and pulmonary hypertension.
What Is It?
The Potts shunt is a direct anastomosis between the descending aorta and the left pulmonary artery (LPA). It creates a systemic-to-pulmonary connection that is physiologically similar to a patent ductus arteriosus (PDA).
Diagram C shows the Potts shunt - descending aorta to left pulmonary artery.
Historical Context (Classic Use)
Originally, the Potts shunt was used as a palliative procedure for cyanotic congenital heart disease (e.g., Tetralogy of Fallot, pulmonary atresia, tricuspid atresia) to augment pulmonary blood flow in infants who could not undergo definitive repair.
However, it has been largely abandoned for this original indication, because:
-
The defect created is difficult to size precisely - it can be undersized (ineffective) or oversized (causing excessive pulmonary flow)
-
Excessive flow triggers pulmonary vascular disease
-
The modified Blalock-Taussig (BT) shunt replaced it, as tube graft size can be precisely selected
-
Fuster and Hurst's The Heart, 15th Ed., p. 1952
Modern Use: Reverse Potts Shunt for Pulmonary Hypertension
The Potts shunt has found a major new application as a palliative procedure for end-stage / refractory pulmonary arterial hypertension (PAH) - particularly in children.
Rationale
By creating a right-to-left shunt at the great artery level, it:
- Reduces right ventricular (RV) afterload - the RV can eject into both the pulmonary artery and, via the shunt, the aorta
- Equalizes systemic and pulmonary pressures, preventing acute RV failure
- Mimics the Eisenmenger physiology - a state that, paradoxically, is associated with better survival than refractory PAH without a shunt
Key Hemodynamic Advantage Over Other Shunts
Compared to atrial septostomy (atrial level) or VSD (ventricular level), the Potts shunt has a unique anatomical advantage:
- It selectively channels desaturated blood to the lower body
- Preserves oxygenated blood delivery to the brain and myocardium (upper body receives pre-shunt, oxygenated blood)
- A 10-15% difference in pre- vs. post-shunt oxygen saturation is considered ideal
Evidence
In one series of 21 patients (mean follow-up >2.5 years), 18 of 21 discharged patients showed:
- Reduction in pulmonary hypertension medications
- Decrease in BNP biomarker
- Clinical improvement
Transcatheter Potts Shunt
A percutaneous/transcatheter variant has been developed as an alternative to open surgery, creating the LPA-to-descending aorta anastomosis via catheter. This has shown benefit in small case series of decompensated PAH.
- Murray & Nadel's Textbook of Respiratory Medicine
- Miller's Anesthesia, 10th Ed., p. 10856-10857
Surgical Approach & Anesthetic Considerations
- Performed via lateral thoracotomy or midline sternotomy
- Anesthetic management is high-risk in PAH patients
- In-hospital mortality: 15-20%
- Monitoring: both upper body (pre-shunt) and lower body (post-shunt) blood pressure and oxygen saturation must be tracked simultaneously
Comparison of Systemic-to-Pulmonary Shunts
| Shunt | Connection | Status |
|---|
| Modified BT shunt | Subclavian artery → ipsilateral PA (via tube graft) | Current standard for CHD palliation |
| Waterston shunt | Ascending aorta → right PA (direct) | Largely abandoned |
| Potts shunt | Descending aorta → left PA (direct) | Abandoned for CHD; used for PAH |
| Glenn shunt | SVC → PA (systemic vein to PA) | Used in single-ventricle staged palliation |
Summary
The Potts shunt is a direct descending aorta-to-left PA anastomosis. Originally a palliative procedure for cyanotic CHD (now replaced by the modified BT shunt), it has been repurposed as a reverse Potts shunt for end-stage pulmonary arterial hypertension. Its anatomical location offers the important advantage of sparing the brain and heart from hypoxic blood while unloading the failing right ventricle - making it superior in concept to atrial or ventricular level shunts for this purpose.